KUALA LUMPUR, Jan 2 Bursa Malaysia opened mixed on the first day of trading week for 2024 despite Wall Street performing lower amid the festive season rally recently, said a.
Pharmaniaga will be the first biggest player in the race of developing its own Malaysian-made halal vaccines by 2024.
WITH the vaccine rollout starting to take on more influence throughout the world and even here in Malaysia, it was no surprise that the pace of Malaysia’s own programme has started to flesh out in greater detail.
That in turn has seen companies, which have long been entrenched in the healthcare theme, beginning to reveal more developments of their strategies.
But more significant news to the investment world in this country was the statement issued by the Securities Commission (SC) to local listed companies announcing plans to be involved in what many see as a money-making venture.